US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.76

+3.523.48%

Post-market: 104.790.0336+0.03%17:10 EDT

Volume:9K

Turnover:922.39K

Market Cap:130.95M

PE:- -

High:105.12

Open:101.84

Low:101.84

Close:101.24

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:0.52

T/O Rate:0.71%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

EBR Systems advances FDA approval process for new WiSE manufacturing site

DBRS Morningstar: Rising rates to hit private corporate credit first and hardest

Morning Star AU

ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17

Hoshino Resorts REIT Wins Interest Rate Cut After Hitting Sustainability Loan Targets

Insmed resumed with a Buy at Goldman Sachs

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange

BOE officials leave London for Leeds to set interest rates

Philip Aldrick / Bloomberg

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

Why Japan’s markets matter so much for America

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

Immunome initiated with a Buy at Alliance Global

Ultragenyx price target raised to $35 from $32 at Barclays

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

Why Mortgage Bonds are Set to Deteriorate, and Possibly Hit the Whole Market, According to This Wall Street Expert

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":104.7564,"timestamp":1791576000000,"preClose":101.2354,"halted":0,"volume":8884,"hourTrading":{"tag":"盘后","latestPrice":104.79,"preClose":104.7564,"latestTime":"17:10 EDT","volume":24,"amount":2518.442,"timestamp":1791580247026,"change":0.0336,"changeRate":0.000321,"amplitude":0},"delay":0,"changeRate":0.0347803238788013,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":3.521,"latestTime":"10-09 16:00:00 EDT","open":101.84,"high":105.12,"low":101.84,"amount":922390,"amplitude":0.0324,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.2354,"sharesOutstanding":600004,"nav":101.653,"aum":127066692.32,"bidAskSpread":0.002364,"postHourTrading":{"tag":"盘后","latestPrice":104.79,"preClose":104.7564,"latestTime":"17:10 EDT","volume":24,"amount":2518.442,"timestamp":1791580247026,"change":0.0336,"changeRate":0.000321,"amplitude":0},"volumeRatio":0.5237741893690447,"impliedVol":0.2112,"impliedVolPercentile":0.1992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5237741893690447,"shares":1250004,"dividePrice":0,"high":105.12,"amplitude":0.0324,"preClose":101.2354,"low":101.84,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":104.7564,"eps":0,"divideRate":0,"volume":8884,"delay":0,"ttmEps":0,"open":101.84,"prevYearClose":79.9149,"prevWeekClose":102.4978,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":102.4978,"twentyDayClose":103.4597,"sixtyDayClose":96.9243},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","TECB","FRTY","MRNX","EES","IBB","MEDI","IDNA","NVIB","TBXU","PINK","BMED","GNMX","GDOC","SYNB","BBP","BK4588","LABU","LFSC","IYH","RSPH","BK4585","PSCH","IEIH","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283878","title":"DBRS Morningstar: Rising rates to hit private corporate credit first and hardest","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283878","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670283878?lang=en_us&edition=fundamental","pubTime":"2026-09-28 00:00","pubTimestamp":1790524800,"startTime":"0","endTime":"0","summary":"Key takeaways:Private credit issuers are most exposed to higher interest rates because of their predominantly floating-rate debt, with rising interest expenses pressuring interest coverage and cash fl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/markets/dbrs-morningstar-rising-rates-hit-private-corporate-credit-first-hardest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/markets/dbrs-morningstar-rising-rates-hit-private-corporate-credit-first-hardest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["CGDV","KI","BDCX","CGHY","UCC","PSP","PSQO","DVDN","FLRN","AFIF","REDS","IGCB","AVSD","KAMO","LONZ","PCMM","DFUV","FXL","BBP","CLIX","PEVC","JCPB","MYCI","PHYD","HYUP","LBO","BIZD","HYZD","VAW","SPHQ","BDCZ","FXR","DYLD","JOJO","RJZ","ANEW","IJK","RSF","TSLP","KOMP","NBFC","CCIF","FBDC","PCLO","DADS","OOSP","SDEF","VPC","CAOS","THYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670099423","title":"ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2670099423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670099423?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:25","pubTimestamp":1790346339,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals (ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, priced its upsized initial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REDS","IPOS","KCE","ADRX","AGNG","LNGR","BK4585","DARP","IBB","RSPH","SYNB","BK4127","XT","FWD","IEIH","BBP","BK4588","FHLC","FRHC","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670443795","title":"Hoshino Resorts REIT Wins Interest Rate Cut After Hitting Sustainability Loan Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2670443795","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670443795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:54","pubTimestamp":1790319243,"startTime":"0","endTime":"0","summary":"An announcement from Hoshino Resorts REIT, Inc. ( ($JP:3287) ) is now available. Hoshino Resorts REIT, Inc. has announced that interest rates on se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hoshino-resorts-reit-wins-interest-rate-cut-after-hitting-sustainability-loan-targets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hoshino-resorts-reit-wins-interest-rate-cut-after-hitting-sustainability-loan-targets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IJK","VAW","TSII","AVSD","TSLW","CAOS","PSCF","ELOL","TSL","TSLL","IQRA","KOMP","BPRE","TSLZ","TSLY","09366","CGDV","RJMG","YLDW","TSLR","IVRA","LRCY","TSLO","09766","CLIX","REIT","TSLP","MDIV","TESC","TSYY","RNTY","TESL","BBP","TEST","RJZ","TLA","CRSH","TSLT","TSLS","FXL","FXR","TSLG","DFUV","TSDD","TSLQ","UCC","ANEW","DFRA","PEVC","TSLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669656404","title":"Insmed resumed with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669656404","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669656404?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:45","pubTimestamp":1790239509,"startTime":"0","endTime":"0","summary":"Goldman Sachs resumed coverage of Insmed (INSM) with a Buy rating and $188 price target Goldman resumed coverage of the biotechnology sector, sayin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004086264.USD","LU0061475181.USD","RKSG","BK4552","TBXU","LU1868837300.USD","LU2237443549.SGD","APXH","FHLC","LU2471134796.USD","FWD","LU2265009873.SGD","LNGR","LU0053671581.USD","XLK","IEIH","GSX","BK4533","BK4585","LU1868837136.USD","INSM","LU0868494708.USD","SYNB","LU0320765992.SGD","LU1894683264.USD","WDNA","LU2896262040.SGD","RSPH","KQQQ","XT","JDOC","BIOY","XLSR","IGM","BBP","IBB","LU2471134523.USD","LU0106831901.USD","BK4588","DARP","LU2750360997.AUD","LU2237443895.HKD","LU2237443465.HKD","AGNG","NFEB","LU1868836757.USD","LU1804176565.USD","IE00B19Z3581.USD","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","BBP","SYNB","NVIB","BK4588","MRNX","IYH","IBB","BK4585","BK4139","GDOC","TBXU","LABU","XLVX","IDNA","RSPH","MRNY","MEDI","IEIH","PINK","LFSC","BMED","GNMX","MESO","FRTY","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188760602","title":"Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1188760602","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188760602?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:46","pubTimestamp":1790174774,"startTime":"0","endTime":"0","summary":"Kaisa Health (00876) has announced a corporate identity overhaul, with its official English name transitioning from \"Kaisa Health Group Holdings Limited\" to \"Qinghai Biotech Pharmaceutical Group...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03069","MRNX","00876","BK1222","BK1154","02954","IBBQ","BK1239","BK1230","BBP","BK1121","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669343196","title":"BOE officials leave London for Leeds to set interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2669343196","media":"Philip Aldrick / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669343196?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:16","pubTimestamp":1790129761,"startTime":"0","endTime":"0","summary":"Monetary Policy Committee's nine members will travel north to the BOE's offices in the West Yorkshire city to thrash out their rate decision, inaugurating a new phase in the bank's 332-year history.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/banking-finance/boe-officials-leave-london-leeds-set-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/banking-finance/boe-officials-leave-london-leeds-set-interest-rates?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["ANEW","BOE","FXR","TLA","TSL","IJK","07766","CLIX","FXL","TSLP","TSLL","PEVC","TSDD","BK4585","TSII","KOMP","AVSD","BK4588","DFUV","RJZ","TESL","TSLS","TEST","BBP","TSLG","TSLQ","TSLZ","07366","VAW","ELOL","09766","TSLI","TESC","TSLO","CGDV","TSLY","TSLT","TSLW","09366","LRCY","UCC","CAOS","TSYY","TSLR","CRSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144262","title":"Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144262","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144262?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080070,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has issued an announcement. Adagene Inc., a platform-driven, clinical-stage biotechnology company listed on Nasdaq, specializes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","BK4139","BBC","LNGR","JDOC","XT","AGNG","DARP","BK4588","BBP","SYNB","FHLC","IBB","IEIH","BK4585","ADAG","NQmain","RSPH","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669989113","title":"Why Japan’s markets matter so much for America","url":"https://stock-news.laohu8.com/highlight/detail?id=2669989113","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669989113?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:01","pubTimestamp":1790049689,"startTime":"0","endTime":"0","summary":"From surging bond yields to US intervention to support the yen, Japan’s financial markets are undergoing major shifts that have consequences for investors and borrowing costs around the globe.Bond yields in Japan have soared to their highest levels in three decades, boosted by inflation, the Bank of Japan raising interest rates and investors’ concerns about the government’s spending plans. Meanwhile, the yen continues to fluctuate after a historic joint intervention by Washington and Tokyo.The moves in Japan’s bonds and currency have reverberations across the global economy. Japan is the largest foreign holder of US Treasuries, making it a key player for how much money flows in or out of US bond markets.US Treasury Secretary Scott Bessent has embarked on an extraordinary campaign this year to intervene in markets to support the yen. Analysts say Bessent’s actions aim to prevent Japan from selling its dollar assets – like Treasuries – to boost the value of the yen. Further selling in Tr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/09/22/economy/us-japan-bond-markets-yen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/09/22/economy/us-japan-bond-markets-yen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["CDIG","IJK","TESC","TSII","ELOL","TSLO","09366","BBP","RJZ","DFUV","CLIX","UCC","CGDV","TSLI","CAOS","YCS","TSLY","TSLL","FXR","07366","TSLT","07766","TSYY","AVSD","TESL","FXL","TSLG","TSLQ","KOMP","TSDD","FXY","TSL","09766","HEWJ","ANEW","TSLP","CRSH","LRCY","BK4585","TEST","TSLR","PEVC","TSLW","TSLZ","TSLS","BK4588","VAW","TLA","YCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","IEIH","BBP","AGNG","SYNB","DARP","JDOC","LNGR","BK4581","TINT","IBB","BK4585","UYM","XBI","FHLC","FWD","BK4588","BK4544","XT","ARKG","TYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199837","title":"Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199837?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:34","pubTimestamp":1790033657,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) just unveiled an announcement. Nexsen Limited, trading on the ASX as NXN, operates in the healthcare and biotechnology...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VHT","BK4550","AGNG","FHLC","NOBL","SYNB","LNGR","FWD","IEIH","IBB","DARP","XT","RSPH","BK4588","BK4585","CGCV","JDOC","IXJ","TCAF","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316610","title":"InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316610?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365503/0/en/inspiremd-announces-amendments-to-certain-series-j-and-series-k-warrants-providing-potential-gross-proceeds-of-up-to-11-million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","IDNA","NVIB","SYNB","BBP","PSCH","RSPH","GDOC","PINK","NSPR","GNMX","BK4588","MRNY","IEIH","BMED","BK4198","MEDI","IBB","BK4585","MRNX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","LNGR","FWD","RSPH","BK4585","XT","DARP","BBC","BBP","BK4588","FHLC","IEIH","JDOC","SYNB","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669893168","title":"Immunome initiated with a Buy at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669893168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669893168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:05","pubTimestamp":1789988705,"startTime":"0","endTime":"0","summary":"Alliance Global initiated coverage of Immunome (IMNM) with a Buy rating and $32 price target Immunome is a biotechnology company focused on develop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LNGR","BK4585","BK4588","RSPH","XT","DARP","BBP","SYNB","FWD","BK4563","IEIH","BK4139","JDOC","IMNM","FHLC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442151","title":"Ultragenyx price target raised to $35 from $32 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442151?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:10","pubTimestamp":1789981807,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Ultragenyx (RARE) to $35 from $32 and keeps an Overweight rating on the shares following FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","LABU","IYH","FRTY","RARE","MEDI","TECB","RSPH","BK4139","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181721651","title":"Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181721651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181721651?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:01","pubTimestamp":1789970464,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, indicating strong upward momentum for select pharmaceutical stocks. This technical indicator, often seen as a precursor to sustained gains, has caught the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","PBE","SBIO","BK1574","LFSC","BIOY","APXH","06978","WRND","GDOC","MEDX","GSKH","BBP","BK4588","BK1161","XLVI","BK4585","LNGR","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669133990","title":"Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669133990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669133990?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:07","pubTimestamp":1789949265,"startTime":"0","endTime":"0","summary":"The latest update is out from Prescient Therapeutics Limited ( ($AU:PTX) ). Prescient Therapeutics Limited, an ASX-listed Australian biotechnology ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-requests-trading-halt-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-requests-trading-halt-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4539","XT","FWD","LNGR","BK4139","BK4585","BK4588","BBP","BK4007","FHLC","JDOC","DARP","IBB","IEIH","SYNB","AGNG","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973580","title":"Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973580","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973580?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761914,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) “announced that the U.S. Food and Drug Administration has approved its lanreotide injection, 120 mg/0.5 mL, in a ster...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IDNA","NVIB","SYNB","XLVX","BBP","BK4007","PSCH","RSPH","GDOC","PINK","FRTY","GNMX","BK4588","MRNY","IEIH","TECB","BMED","IYH","LABU","MEDI","AMRX","IBB","BK4585","MRNX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668925492","title":"Why Mortgage Bonds are Set to Deteriorate, and Possibly Hit the Whole Market, According to This Wall Street Expert","url":"https://stock-news.laohu8.com/highlight/detail?id=2668925492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668925492?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:40","pubTimestamp":1789735200,"startTime":"0","endTime":"0","summary":"But hyperscaler bonds are in decent shape, says Harley BassmanFor sale signs are posted in front of condominiums for sale on July 09, 2026 in Los Angeles, California. Harley Bassman, bond-market veter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLP","BBAG","TAGG","BNDP","AVSD","BBP","FXL","AGZD","TMF","US2Y.BOND","JPO","HIGH","US10Y.BOND","LFAO","BNDW","JHMB","PEVC","GHMS","MORT","TLT","VPLS","SPAB","LSTB","IUSB","CAOS","FXR","US30Y.BOND","RJZ","VAW","CGDV","IJK","KOMP","ADFI","IBTJ","UCC","AGGY","LRCY","TLTW","JBND","DFUV","TSLR","US7Y.BOND","US5Y.BOND","PYLD","DEED","US6M.BOND","ANEW","US3Y.BOND","CLIX","US12M.BOND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}